Considerations for Earlier Use of Radiopharmaceutical Therapy in Prostate Cancer
- Details
- Publication Year 2026-07,Volume 90,Issue #1,Page 1-6
- Journal Title
- European Urology
- Publication Type
- Editorial
- Abstract
- Local and androgen-deprivation therapies are guideline recommendations in localized and metastatic prostate cancer, respectively. However, in select patients the alternative use of radiopharmaceutical therapies may be considered to delay or avoid quality-of-life decline associated with other systemic treatments.
- Publisher
- Elsevier
- Keywords
- Humans; Male; *Prostatic Neoplasms/radiotherapy/pathology/drug therapy; Quality of Life; *Radiopharmaceuticals/therapeutic use; Time Factors
- Department(s)
- Surgical Oncology
- Publisher's Version
- https://doi.org/10.1016/j.eururo.2026.03.002
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-04-28 02:39:58
Last Modified: 2026-08-04 04:43:04